Reports for BAXTER CORPORATION
Company Name
BAXTER CORPORATION
Totals |
||
Shortage reports |
197 |
|
Actual shortage: | 7 (4%) | |
Anticipated shortage: | 1 (1%) | |
Avoided shortage: | 3 (2%) | |
Resolved: | 186 (94%) | |
Discontinuation Reports |
26 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 26 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
11 (5%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
CLINDAMYCIN INJECTION IN 5% DEXTROSE | 600MG | SOLUTION | Resolved | 2020-09-02 | 2020-09-17 | 123592 |
BREVIBLOC INJECTION 10MG/ML | 10MG | SOLUTION | Resolved | 2020-10-20 | 2020-11-10 | 126749 |
20% PROSOL | 1.44G 1.35G 1.18G 1.08G 1.08G 1G 0.98G 0.76G 0.32G 2.76G 2.06G 1.96G 1.34G 1.02G 1.02G 0.6G 0.05G | LIQUID | Resolved | 2021-01-28 | 2021-03-02 | 132584 |
HEPARIN SOD AND 0.9% SOD CHLORIDE INJ | 2UNIT 9MG | SOLUTION | Resolved | 2021-07-07 | 2021-09-22 | 141925 |
CLINIMIX | 20MG 210MG 90MG 210MG 220MG 230MG 240MG 520MG 1.04G 1.04G 290MG 290MG 310MG 310MG 10G | SOLUTION | Resolved | 2021-09-07 | 2021-10-21 | 145265 |
CLINIMIX | 220MG 230MG 240MG 520MG 1.04G 1.04G 290MG 290MG 310MG 310MG 20G 20MG 210MG 90MG 210MG | SOLUTION | Resolved | 2021-09-07 | 2021-11-26 | 145268 |
CLINIMIX E | 58.5MG 261MG 205MG 20MG 210MG 90MG 210MG 220MG 230MG 240MG 520MG 1.04G 290MG 290MG 310MG 310MG 10G 1.04G 24MG | SOLUTION | Resolved | 2021-09-07 | 2021-10-25 | 145271 |
CLINIMIX E | 520MG 24MG 58.5MG 261MG 205MG 20MG 210MG 90MG 210MG 220MG 230MG 240MG 1.04G 1.04G 290MG 290MG 310MG 310MG 16.6G | SOLUTION | Resolved | 2021-09-07 | 2021-11-26 | 145274 |
CLINIMIX | 290MG 280MG 365MG 16.6G 20MG 515MG 250MG 340MG 575MG 1.04G 90MG 210MG 240MG 290MG 300MG 200MG | SOLUTION | Resolved | 2021-09-07 | 2021-11-26 | 145277 |
TRAVASOL | 730MG 500MG 40MG 680MG 1.15G 1.03G 2.07G 180MG 420MG 480MG 580MG 600MG 580MG 400MG 560MG | SOLUTION | Resolved | 2021-09-07 | 2021-10-02 | 145280 |
TRAVASOL | 730MG 500MG 40MG 680MG 1.15G 1.03G 2.07G 180MG 420MG 480MG 580MG 600MG 580MG 400MG 560MG | SOLUTION | Resolved | 2021-09-23 | 2021-10-02 | 146106 |
20% PROSOL | 1.44G 0.05G 0.6G 1.02G 1.02G 1.34G 1.96G 2.06G 2.76G 0.32G 0.76G 0.98G 1G 1.08G 1.08G 1.18G 1.35G | LIQUID | Resolved | 2021-09-23 | 2021-10-02 | 146109 |
DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP | 50MG .8MG | SOLUTION | Resolved | 2021-09-30 | 2021-12-09 | 146385 |
CLINIMIX | 240MG 290MG 290MG 310MG 310MG 16.6G 20MG 210MG 520MG 1040MG 1040MG 90MG 210MG 220MG 230MG | LIQUID | Resolved | 2021-10-13 | 2021-10-25 | 147032 |
TRAVASOL | 730MG 500MG 40MG 680MG 1.15G 1.03G 2.07G 180MG 420MG 480MG 580MG 600MG 580MG 400MG 560MG | SOLUTION | Resolved | 2021-10-13 | 2021-11-05 | 147113 |
70% DEXTROSE INJECTION USP | 70G | SOLUTION | Resolved | 2021-10-13 | 2021-11-05 | 147116 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2021-12-06 | 2022-09-17 | 150508 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2021-12-06 | 2022-09-02 | 150511 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2021-12-06 | 2022-08-24 | 150514 |
0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | SOLUTION | Resolved | 2021-12-06 | 2022-07-23 | 150517 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120955 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120958 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120961 |
POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 5G 900MG 300MG | SOLUTION | Discontinued | 2020-11-26 | 2021-02-02 | 128947 |
1.6% SODIUM CHLORDIE PROCESSING SOLUTION | 1.6G | SOLUTION SOLUTION | Discontinued | 2022-12-13 | 2023-01-01 | 178273 |
CLINDAMYCIN INJECTION IN 5% DEXTROSE | 300MG | SOLUTION | Discontinued | 2023-02-06 | 2023-04-02 | 183710 |